Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will present at the Jefferies Global Healthcare Conference in London on November 18, 2025 at 11:30 AM GMT.
A live webcast of the presentation will be available via the company's investor relations website and will be available for replay for approximately 30 days following the event.
Whitehawk Therapeutics (Nasdaq: WHWK) ha annunciato che Dave Lennon, PhD, Presidente e CEO, terrà una presentazione alla Jefferies Global Healthcare Conference a Londra il 18 novembre 2025 alle ore 11:30 GMT.
Una trasmissione in diretta della presentazione sarà disponibile sul sito di relazioni con gli investitori dell'azienda e sarà disponibile per la riproduzione per circa 30 giorni dopo l'evento.
Whitehawk Therapeutics (Nasdaq: WHWK) anunció que Dave Lennon, PhD, Presidente y CEO, presentará en la Conferencia Global de Salud de Jefferies en Londres el 18 de noviembre de 2025 a las 11:30 AM GMT.
Una transmisión en vivo de la presentación estará disponible a través del sitio web de relaciones con inversionistas de la empresa y estará disponible para su reproducción durante aproximadamente 30 días después del evento.
Whitehawk Therapeutics (Nasdaq: WHWK)는 Dave Lennon, PhD, 사장 겸 CEO가 런던에서 열리는 Jefferies Global Healthcare Conference에서 2025년 11월 18일 11:30 GMT에 발표할 예정이라고 발표했습니다.
발표의 라이브 웹캐스트는 회사의 투자자 관계 웹사이트를 통해 시청 가능하며 이벤트 이후 약 30일간 재생할 수 있습니다.
Whitehawk Therapeutics (Nasdaq: WHWK) a annoncé que Dave Lennon, PhD, président et directeur général, présentera lors de la Jefferies Global Healthcare Conference à Londres le 18 novembre 2025 à 11h30 GMT.
Une diffusion en direct de la présentation sera disponible via le site web des relations investisseurs de l'entreprise et sera disponible en replay pendant environ 30 jours après l'événement.
Whitehawk Therapeutics (Nasdaq: WHWK) gab bekannt, dass Dave Lennon, PhD, Präsident und CEO, auf der Jefferies Global Healthcare Conference in London am 18. November 2025 um 11:30 GMT auftreten wird.
Eine Live-Übertragung der Präsentation wird über die Investor-Relations-Website des Unternehmens verfügbar sein und wird ca. 30 Tage lang nach der Veranstaltung zur Wiederholung bereitstehen.
Whitehawk Therapeutics (Nasdaq: WHWK) أعلنت أن ديف ليـنـن، دكتوراه، الرئيس التنفيذي والمدير العام، سيقدم في مؤتمر Jefferies Global Healthcare Conference في لندن في 18 نوفمبر 2025 في الساعة 11:30 صباحاً بتوقيت GMT.
سيكون البث المباشر لعرضه متاحاً عبر موقع علاقات المستثمرين الخاص بالشركة، وسيكون قابلاً لإعادة البث لمدة حوالي 30 يوماً عقب الحدث.
- None.
- None.
A live webcast of the presentation can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available at www.whitehawktx.com and connect with us on LinkedIn.
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-jefferies-global-healthcare-conference-in-london-302611063.html
SOURCE Whitehawk Therapeutics, Inc.